Home/Filings/4/0000904454-14-000803
4//SEC Filing

GENOCEA BIOSCIENCES, INC. 4

Accession 0000904454-14-000803

CIK 0001457612operating

Filed

Dec 14, 7:00 PM ET

Accepted

Dec 15, 7:15 PM ET

Size

5.4 KB

Accession

0000904454-14-000803

Insider Transaction Report

Form 4
Period: 2014-04-07
Poole Jonathan
Chief Financial Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2014-04-07+200,726200,726 total
    Exercise: $17.89Exp: 2024-04-06Common Stock (200,726 underlying)
Footnotes (1)
  • [F1]The option was granted on 4/7/2014 and 25% of the shares will vest on 4/7/2015, with the remainder vesting in equal monthly installments over the three years thereafter.

Issuer

GENOCEA BIOSCIENCES, INC.

CIK 0001457612

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001457612

Filing Metadata

Form type
4
Filed
Dec 14, 7:00 PM ET
Accepted
Dec 15, 7:15 PM ET
Size
5.4 KB